174 related articles for article (PubMed ID: 16652329)
1. Tenofovir-associated kidney diseases and interactions between tenofovir and other antiretrovirals.
Lanzafame M; Lattuada E; Rapagna F; Gottardi M; Vento S
Clin Infect Dis; 2006 Jun; 42(11):1656-7; author reply 1658. PubMed ID: 16652329
[No Abstract] [Full Text] [Related]
2. The role of drug interactions and monitoring in the prevention of tenofovir-associated kidney disease.
Winston JA; Shepp DH
Clin Infect Dis; 2006 Jun; 42(11):1657-8; author reply 1658. PubMed ID: 16652330
[No Abstract] [Full Text] [Related]
3. Tenofovir and didanosine: a dangerous liaison.
Waters L; Maitland D; Moyle GJ
AIDS Read; 2005 Aug; 15(8):403-6, 413. PubMed ID: 16110555
[No Abstract] [Full Text] [Related]
4. Tenofovir-induced acute renal failure in an HIV patient with normal renal function.
Krummel T; Parvez-Braun L; Frantzen L; Lalanne H; Marcellin L; Hannedouche T; Moulin B
Nephrol Dial Transplant; 2005 Feb; 20(2):473-4. PubMed ID: 15673708
[No Abstract] [Full Text] [Related]
5. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
Psevdos G; Gonzalez E; Sharp V
AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
[TBL] [Abstract][Full Text] [Related]
6. Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir.
Cicconi P; Bongiovanni M; Melzi S; Tordato F; d'Arminio Monforte A; Bini T
Int J Antimicrob Agents; 2004 Sep; 24(3):284-5. PubMed ID: 15325433
[TBL] [Abstract][Full Text] [Related]
7. Acute renal failure after initiation of tenofovir disoproxil fumarate.
Hynes P; Urbina A; McMeeking A; Barisoni L; Rabenou R
Ren Fail; 2007; 29(8):1063-6. PubMed ID: 18067059
[TBL] [Abstract][Full Text] [Related]
8. Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases.
Blaas S; Schneidewind A; Glück T; Salzberger B
AIDS; 2006 Aug; 20(13):1786-7. PubMed ID: 16931948
[No Abstract] [Full Text] [Related]
9. Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases.
Sabbatini F; Prati F; Borghi V; Bedini A; Esposito R; Mussini C
Infection; 2007 Dec; 35(6):474-6. PubMed ID: 18034206
[No Abstract] [Full Text] [Related]
10. Editorial comment: mixing tenofovir with other nephrotoxins--how safe is this?
Gupta SK
AIDS Read; 2009; 19(6):246. PubMed ID: 19642244
[No Abstract] [Full Text] [Related]
11. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
Gallant JE; Parish MA; Keruly JC; Moore RD
Clin Infect Dis; 2005 Apr; 40(8):1194-8. PubMed ID: 15791522
[TBL] [Abstract][Full Text] [Related]
12. Improvement of dyslipidemia during different HAART regimens: tenofovir- versus stavudine-containing antiretroviral combinations.
Manfredi R
Clin Infect Dis; 2006 May; 42(9):1345-7; author reply 1347-8. PubMed ID: 16586399
[No Abstract] [Full Text] [Related]
13. Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome.
Schaaf B; Aries SP; Kramme E; Steinhoff J; Dalhoff K
Clin Infect Dis; 2003 Aug; 37(3):e41-3. PubMed ID: 12884188
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir: what have over 1 million years of patient experience taught us?
Pozniak A
Int J Clin Pract; 2008 Aug; 62(8):1285-93. PubMed ID: 18705824
[TBL] [Abstract][Full Text] [Related]
15. Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.
Crane HM; Kestenbaum B; Harrington RD; Kitahata MM
AIDS; 2007 Jul; 21(11):1431-9. PubMed ID: 17589189
[TBL] [Abstract][Full Text] [Related]
16. Possible allergic cross-reaction to didanosine and tenofovir in an HIV-1-infected woman.
Ripamonti D; Maggiolo F; Suter F
AIDS; 2007 May; 21(8):1059-60. PubMed ID: 17457107
[No Abstract] [Full Text] [Related]
17. Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir.
Barreiro P; Soriano V
J Antimicrob Chemother; 2006 May; 57(5):806-9. PubMed ID: 16531427
[TBL] [Abstract][Full Text] [Related]
18. Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?
Badiou S; De Boever CM; Terrier N; Baillat V; Cristol JP; Reynes J
J Infect; 2006 May; 52(5):335-8. PubMed ID: 16176835
[TBL] [Abstract][Full Text] [Related]
19. [Renal adverse reactions of antiretroviral medication: proximal tubular dysfunction associated with tenofovir].
Kuijper A; Rookmaker MB; Mudrikova T
Ned Tijdschr Geneeskd; 2011; 155():A2249. PubMed ID: 21418698
[TBL] [Abstract][Full Text] [Related]
20. Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting.
Manosuthi W; Prasithsirikul W; Tantanathip P; Chimsuntorn S; Nilkamhang S; Sungkanuparph S
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):643-50. PubMed ID: 21706942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
